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ABSTRACT. Novel formulations for deet in liposphere microdispersion in the form of lotion were
prepared from natural solid triglycerides and phospholipids dispersed in buffer solution. The formulations
"ont ini.tg 6.5, lO, and 20% Get were efective as a repellent against the common aggressive biting
mosquitois, Aedes'aegypti and Anopheles stephensi, for up to 6 h. The acute dermal absorption of the
l0% ioaded formulation was conducted in rabbits using 'aCJabeled deet. 'aClabeled deet, l0% in alcohol
solution or in liposphere microdispersion was applied to the intact rabbit skin undera porous nonirritating
cover for 7 dayi. Plasma levels ofradioactivity were determined for 24 h, and daily for a total of 7 days.
The taC-deet blood levels following intravenous bolus administration were also measured. The bioavail-
ability of deet from I 0% ethanol solution was 45%, whereas the bioavailability of deet from lipospheres
*"r i6%. a 3-fold reduction in the amount of deet absorbed. Examination of the rabbits during the
experiment and after necropsy showed no evidence of toxicity or irritation. The l0% deet-liposphere
formulation was stable at room temperature for at least I year.
INTRODUCTION
Insects such as mosquitoes, flies, and fleas are
a significant factor in the spread ofserious dis-
eases including malaria and encephalitis. They
are a general nuisance to humans and animals.
Efforts to repel these insect pests, other than
physical means, are generally effective for less
than 3 h. A common means for repelling insects
consists of applying the compound N,N-diethyl-
m-toluamide (deet) to the skin. The commer-
cially available liquid deet formulations contain
between l5 and l00o/o deet and they are not rec-
ommended for use on children. The toxicity of
deet has been extensively reported and related
to its high skin absorption after topical admin-
istration (Reuveni and Yagupsky 1982, Snod-
grass et al. 1982, Robbins and Cherniak 1986,
Mody 1989, Mody et al. 1989, Lipscomb et al.
1992, Clem et al. 1993). Previous studies have
demonstrated that as much as 50% of a topical
dose of deet was systematically absorbed (Snod-
gmss et al. 1982, Robbins and Cherniak 1986,
Mody 1989, Lipscomb et al. 1992). Several
methods have been reported for increasing the
duration of deet effectiveness (Gupta and Rut-
ledge 1989, Raden 1989, Schreck and Kline
1989). These methods used polymer solutions
that form a film on skin, complexes of deet with
aromatic proton donor carriers, or acrylate-based
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microcapsules dispersed in oil in water emulsion.
However, none showed a significant improve-
ment over alcoholic solutions ofdeet (Gupta and
Rutledge 1989, Schreck and Kline 1989).
A novel encapsulation system, referred to as
liposphere, was developed for the delivery of
bioactive compounds by parenteral injection or
for topical application (Amselem et al. 1992a,
1992b; Domb 1993a, 1993b; Masters and Berde
I 994). The system is an aqueous microdispersion
of all-natural, solid, water-insoluble spherical
microparticles of 0.2-100 pm in diameter. The
liposphere microparticles are made of hydro-
phobic solid triglycerides having a layer ofphos-
pholipids embedded on the surface of the par-
ticle. The solid core contains the bioactive
compound dissolved or dispersed in the solid fat
matrix. The system has been effective in con-
trolled delivery of antibiotics and anti-inflam-
matory agents for 3-5 days after a single injection
(Domb 1993a, 1993b). Lipospheres have also
been used for the delivery of vaccines (Amselem
ei al. 1992a, 1992b) and local anesthetics (Mas-
ters and Berde 1994).
In an effort to develop a new topical formu-
lation for deet that possesses reduced skin ab-
sorption as well as an increase in the duration of
repellency, we have encapsulated deet into li-
pospheres and studied its skin absorption dy-
namics and duration ofaction. We hypothesized
that encapsulation of deet will reduce its contact
surface area with skin and reduce its evaporation
rate from the skin surface, resulting in reduced
dermal uptake and extended repellent activity.
We report the preparation ofa deet-encapsulated
liposphere system, its repellent activity, and the
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systemic absorption of topically administered
deet-liposphere formulations.
MATERIAIS AND METHODS
Materials: Deet was a gift from Morflex Inc.
(Greensboro, NC) and contained 95olo N,N-di-
ethyl-m-toluamide and 5olo related isomers. Ra-
diolabeled deet (carbonyl C-14) 12.92 mCi,/mmol
with a radiochemical purity of > 98.60lo was pur-
chased from New England Nuclear (Boston, MA).
Hydrogenated vegetable oil (Sterotex@, melting
point 65'C) was purchased from Capital City
Products (Columbus, OH). I€cithin (Centrolex-
D@) was purchased from Central Soya (Fort
Wayne, IN). Dibasic sodium phosphate and
monobasic potassium phosphate were purchased
from EM Science (Cherry Hill, NJ). Propylpar-
aben and methylparaben were obtained from
Napp Chemicals Inc. (Lodi, NJ). All water used
in this study was deionized. Absolute ethanol
waspurchasedfrom Quantum (Newark, NJ). New
Znaland white rabbits, 16 males weighing 4 kg,
were purchased from Myrtle's Rabbitry (Jackson
Station, TN).
Preparation of liposphere formulations.' For-
mulations containing l09o deet were prepared by
the addition of deet (10 g) and propylparaben
(0.05 g) to 12.5 g of melted hydrogenated vege-
table oil, followed by the addition of 72.5 ml
phosphate buffer (pH 7.4, O.O5 M) containing
methylparaben (0.10 g) and lecithin (5 g). The
mixture was homogenized for 2 min using a Sil-
verson L4 homogenizer (Silverson Machines,
Waterside, England) to form a homogeneous dis-
persion and then cooled to room temperature to
form a smooth, easy-to-apply lotion. Formula-
tions containing 0 and 6.59o deet were prepared
similarly; the formulation containing 20o/o deet
was prepared using 20% hydrogenated vegetable
oil.
Preparation of radiolabeled doses.' The intra-
venous doses contained 160 pCt/8O mg of deet.
The deet-liposphere formulation contained 20
pCi per gram of l09o formulation (20 ttCt/lDO
mg deet). The radiolabeled deet liposphere for-
mulation was prepared from deet (20 pCt/100
mg), hydrogenated vegetable oil, phosphate bufl
er, and phospholipid as described above. The
alcoholic solution was prepared by the dilution
of radiolabeled deet with ethanol to form a l0o/o
solution containing 2O pCi/lOO mg deet.
Characterization of lipospheres: Particle size
of the liposphere formulations was determined
using a Coulter LSl00 particle size analyzer. The
SEM analysis was conducted on a Philips 70
scanning electron microscope. The content ofthe
phospholipid on the surface oflipospheres was
determined by the trinitrobenzenesulfonic acid
(TNBS) method using liposphere formulations
containing phosphatidylethanolamine (PE) (New
1990). Deet content in lipospheres was deter-
mined by gas chromatogaphy (GC) conducted
on a Hewlett Packard 5890 GC with a HP 33964
integrator and a flame ionization detector.
An HP Ultra2 (25 m x 0.2 mm x 0.ll mm),
methyl phenyl silicone 506 column was used. The
following conditions were used: detector and in-jector temperatures were 260'C. column tem-
perature was 150"C, and helium gas at 40 psi.
Viscosity measurements of formulations were
conducted using an RTV Brookfield viscometer(Brookfield I-abs., Stoughton, MA) using a Hal-
ipath spindle # B.
S t orage stability : T en prcent deet-liposphere
formulations (10 g) packed in l0-ml glass con-
tainers were stored at 4'C and 25'C in 600lo hu-
midity cabinets and the particle size, deet con-
tent, viscosity, and appearance were monitored
for 12 months. Samples were analyzed in trip-
licate at 0, l, 3, 6, and, 12 months of storage.
Eftcacy stu.dies: The residual efficacy of li-
posphere formulations was evaluated on 3 vol-
unteers who had given informed consent. The
formulations were applied to the skin and ex-
posed to mosquitoes. The time of 100% repel-
lency (zero biting) was the index for determining
the effectiveness of a formulation.
The formulations were applied on 4locations
on the arm of volunteers at a concentration of
2.5 mg/cm2 on a total area of 12 cm2 skin surface.
Mosquitoes were placed in a screen-bottomed
(18 mesh netting, l0-cm2 exposure arca) l-oz.
cylindrical cup, made of clear polymethacrylate,
containing l5 5-I5-day-old female mosquitoes
displaying host-seeking behavior with access to
the skin through the netting. The forearm was
placed on the mosquito netting for l0 min every
30 min and the number of biting mosquitoes
(evident by a blood meal) was recorded. Prior to
any efficacy experiment the mosquitoes were
tested on untreated skin to confirm their host-
seeking behavior. Two mosquito species were
tested: Aedes aegypti (Linn.) and, Anopheles ste-
phensi Liston, both aggressive biters.
Skin absorption studies: The pharmacokinetic
profile of deet in rabbits was determined after
intravenous administration (Group IV) and top-
ical administration of l0o/o deet in ethanol (Group
A) and l0o/o deet in lipospheres (Group B). Six-
teen rabbits were used in the study; 8 rabbits
received intravenously 2O p.Cr/lo mglkg of ra-
diolabeled deet in alcohol (Group IV). After a
washout period of 3 days, 8 of the 16 rabbits
received a l-g/kg topical dose of l07o deet in
ethanol (Group A) and 8 rabbits received a l-gl
kg topical dose of l09o deet in lipospheres (Group
B). A summary of the experimental groups is
shown in Table l.
Preparation of the rabbits for the study: TllLe
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Table l. Experimental groups used in the rabbit skin absorption study.
Experimental group
Intravenous (IV) ?
Administration
No. of rabbits
Formulation
Dose administered
(formulation)
Dose administered (deet)
Dose administered (pCi)
IV―blood levels
8
100//o in alcohol
O.l m1/kg
10 mg/kg
20 μCi
topical-liposphere
8
100//o in liposphere
lg/kg
100 mg/kg
20 μCi
topical――alcohol
8
109/o in alcohol
ly雑
100 mg/kg
20 μCi
animals were housed in metabolic cages for the
7 days of the study and allowed free access to
food and water. Prior to application ofthe topical
doses, the back and neck of the rabbits were
shaved. On the day of the study, the adminis-
tration area was outlined with a 0.25-in.-high
strip of polystyrene tape (secured to the animal
with paper tape) in order to form a barrier for
the dose.
Administration of radiolabeled doses: Intra-
venous doses containing one-tenth ofthe deet of
the topical dose, but the same amount of radio-
activity, were administered via the marginal ear
vein over 15 sec and flushed with 0.906 NaCl.
Topical administration was accomplished by ap-
plication of the material to a 64-cm2 square area
of rabbit skin, which approximates l0o/o of the
body surface area in a 4-kg rabbit. Rabbits re-
ceived deet-liposphere formulation dose of I
gkg over a 8 x 8-cm2 skin area. A nonocclusive
cloth was then secured to the top ofthe barrier
wall in order to collect evaporated deet, and the
body of the rabbit wrapped to prevent removal
of the patch. An Elizabethan collar was placed
on the rabbit to inhibit animal access to the ad-
ministration area. The residual dose was re-
moved from the skin by washing and quantitated
after 24 h.
Collection of samples: A heparin lock was
placed in the ear of the rabbit for collection of
the first several blood samples after administra-
tion ofthe intravenous and topical doses. Before
drawing the samples, the lock was cleared ofhep-
ainized saline. Samples of 1.0 ml of blood were
drawn at 0, 5, 10, 15, 30, 45,60, and 90 min,
and at 2, 3, 4, 6, 6.5, 7, 7.5, 8, 9, and l0 h for
the intravenous doses. A sample was drawn im-
mediately before administration of the topical
dose for validation of the washout period. After
topical administration, blood samples were drawn
at  0,  5,  15,  30,  45,60,90,  120,150,  190,  and
210 min, andat4,5,6,8, 12, 16, and 24 h, and
daily for a total of7 days.
Urine was collected 24h after intravenous ad-
ministration and after l, 2, and,3 days in each
of the rabbits administered a topical dose. The
rabbits were sacrificed by isoflurane overdose af-
ter 7 days. The application sites of the skin were
collected and frozen at -70'C until analysis.
Determination of radioactivity in specimens:
The specimens (blood, urine, skin, patch, and
washings from dose removal) were homogenizec
and a known aliquot treated with tissue solubi-
lizer (Soluable@, New England Nuclear) and de-
colorized with 30% hydrogen peroxide (Sigma,
St. Louis, MO) according to the manufacturer's
directions. The samples were then suspended in
scintillation cocktail and the radioactivity quan-
titated by liquid scintillation counting. Scintil-
lation counting was performed according to stan-
dard operating procedures on a Beckman
LS6000 I C liquid scintillation counter (Beckman
Instruments, Colombia, MD) equipped with in-
ternal quench and eftciency adjustments. Each
sample was analyzed in triplicate and the mean
taken as the true value.
Data analysis.' The recovery of the radioac-
tivity administered was calculated based upon
the radioactive content ofthe organs tested, skin,
patch removed, and urinary excretion. The ab-
solute bioavailabi-lity was computed from the area
under the curve (AUC) of a plot of radioactive
content in the blood stream versus time, using
piecewise trapezoidal integration. The mean
AUCs of the group of rabbits receiving the top-
ical applications were compared to the AUCs of
the group of animals receiving the intravenous
administration (each was corrected for dose) us-
ing the following formula:
9o absolute bioavailability
: {(AUC [topical/(AUc UVD] x 100.
RESULTS AND DISCUSSION
Preparation and characterization of dea- load-
ed liposp heres : The liposphere microdispersions
containing deet incorporated in solid triglyceride
particles were prepared by the melt method using
common natural ingredients in one step without
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Table 3. Repellency effectiveness ofdeet-
liposphere formulations.'
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Fig. 3. Blood concentrations @PM/ml) after in-
travenous and topical administration of l0% deet in
ethanol solution. Ten percent deet solution (l ml, 20
pCt/ml) administered intravenously (IV) or topically(surface area 64 cm2) to rabbits. Results are average of
8 rabbits.
also based on the assumption that the rate of
elimination is not dose dependent and that elim-
ination after bolus intravenous administration is
the same as elimination after topical adminis-
tration.
Table 4 summarizes the total urinary content
of taC after intravenous and topical administra-
tion of deet formulations. About 74o/o f tlrleIV-
administered dose was collected in the urine, and
39 and l9Vo of the topically administered doses
were collected for the alcoholic and liposphere
formulations, respectively. Optimal collection of
urine was difficult in the metabolic cages used in
this experiment as evident from the large vari-
ation in urine collection (74 + 23).Assuming
that the error in urine collection is similar in all
experiments, the difference in radioactivity con-
tained in the urine after topical administration
ofthe liposphere dosage form is about 50% that
ofthe alcoholic dose, which corresponds to the
blood bioavailability calculations. The total
amount of deet recovered from skin (washing of
residual dose and extraction from skin) was sim-
ilar for both formulations, indicating that both
formulations were similarly exposed to the skin
Number biting Aedes aegypti
and, A nopheles stephensi
????
】
?
?
?
??
??
．?
U n―
trcat, Con‐
ed2  tr012
o/o deet in
formulation Refer-
ence3
15 2(5
30  5(4
60  3(5
90  3(5
120  5(5
150 5(3
180  3(5
210  4(4
240  5(3
270  3(4
300 4(6
380  5(6
0(0) 0(0) 0(0)
0(0) 0(0) 0(0)
0(0) 0(0) 0(0)
0(0) 0(0) 0(0)
0(0) 0(0)  1(1)
0(0) 0(0) 0(1)
0(0) 0(0)  1(2)
0(0) 0(0)  1(1)
0(2)  0(0) 2(1)
0(2)  0(0)
1(2)  0(0)
0(0)
4(0)
5Q)
5(3)
5(3)
5(5)
5(5)
4(4)
5(3)
3(4)
4(3)
4(5)
5(5)
0(0)
0(0)
0(0)
0(0)
0(0)
00)
?
?
?
?
(1)
(1)
(2)
2(2)
3(2)
' Cups with mosquitoes were placed for l0 min every 30
min on the skin of volunteers treated with formulation (2.5
mglcm2), and the number ofbites were recorded. The results
are average of 3 independent tests (cup placements), fie results
in parentheses arc of An. stephensi.
2 Untreated test was without any treatment, Control was a
deet-free liposphere formulation.
3 Reference formulation was 1096 by weight ofdeet in eth-
anol.
deet l0o/o in lipospheres (Group B). Figure 4 rep-
resents the blood concentration following topical
administration data from Fig. 3 so that they may
be compared directly on an expanded concen-
tration axis. The AUC after topical dosing was
24,494 DPM/ml for Group A (l0o/o alcohol so-
lution) and 8,444 DPM/ml for group B (lipo-
sphere formulation). Therefore, the absolute bio-
availability ofdeet from a l0% ethanol solution
was 45olo, whereas the bioavailability from li-
pospheres was only 160/o, a 3-fold reduction in
the amount ofdeet absorbed. This result is based
on the assumptions that the absorption of deet
from lipospheres and ethanol vehicles is a com-
parison of absorption only. The conclusion is
Table 4. Recovery of taC-deet in urine and skin of rabbits after intravenous (IV) and topical
administration of alcoholic or liposphere formulation.t
Percent recovery + SD
Dose type Urine sttn2 Total
IV‐―alcohol
Topical―alcohol
Topical-liposphcrc
74± 23
39± 5(53)
19± 8(26)
74± 23
?
?
?
?
?
?
?
?
?
± 3(65)
±8(38)
I Results are % of administered dose, the numbers in parentheses are the corrected values for 74% recovery after intravenous
administration.
' Combined radioactivity from washings and skin tissue content.
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Fig. 4. Blood concentrations (DPM,/ml) after top-
ical administration of I 0% deet in ethanol or liposphere
formulation. Formulations l0% containing deet (l ml,
20 pCilml) administered topically (surface area 64 crn2)
to rabbits. Results are average of 8 rabbits.
and thus the results are comparable. The non-
recovered deet after topical administration is
probably due to evaporation of deet from the
nonocclusive patches to the environment. The
lower deet recovery of the liposphere formula-
tion can be interpreted as more deet is released
to the environment resulting in more repellent
activity.
Conclusions: Encapsulation ofdeet in a novel
stable liposphere microdispersion system result-
ed in improved efficacy and reduced dermal ab-
sorption. Deet-containing lipospheres (10%) were
effective against mosquitoes for at least 3.5 h.
The deet absorption through skin from these for-
mulations was a third of that from alcoholic so-
lution for the same concentration. The improved
efficacy and reduced dermal absorption of deet,
in addition to its composition of only 1006 deet
content encapsulated in common natural ingre-
dients and the simple method of preparation,
make this formulation attractive for consumer
use.
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